A subsidiary investment firm of a leading China-focused private equity fund is actively looking for equity investment, in-licensing, or add-on acquisition opportunities to augment its healthcare portfolio. The size of investment varies depending on the deal. The firm considers businesses in China and the United States.
Within healthcare, the firm considers a wide range to technologies including pharmaceuticals, medical devices, diagnostic tools, and healthcare IT. The firm is interested in products with large market potential in China in a wide range of therapeutic categories. The firm is open to companies at various stages of development but prefers products that have obtained human proof-of-concept.
The firm looks for products with a China angle and may request China distribution rights on a case-by-case basis.
If you are interested in more information about this investor and other investors tracked by LSN, please email email@example.com